No By
George B. Zavoice PH.D.
and www.mlvco.com
Buy, 10 dollars. They really give it a 20 dollar target with a 50% discount because of certain risks. But it is still a BUY, and a 10 dollar target.
and before you bash MLV, or Dr. Zavoice...here is his back ground.
George B. Zavoico, Ph.D., has over 6 years of experience as a life sciences analyst writing research on publicly traded equities. He has most recently worked at Westport Capital Markets and Cantor Fitzgerald in their research departments and has received The Financial Times/Starmine Award two years in a row for being among the top-ranked Earnings Estimators in the Biotechnology Sector. His principal focus is on biotechnology, biopharmaceutical, specialty pharmaceutical, and molecular diagnostics companies engaged in discovering, developing, and marketing drugs and value-added diagnostics for the diagnosis and treatment of cancer and cardiovascular and inflammatory/immune diseases and disorders.
Prior to working as an analyst, Dr. Zavoico established his own consulting company serving the biotech and pharmaceutical industries by providing competitive intelligence and marketing research, due diligence services, and guidance in regulatory affairs. He also wrote extensively on healthcare and the biotech and pharmaceutical industries for periodicals targeting the general public and industry executives. Dr. Zavoico began his career as a Senior Research Scientist at Bristol-Myers Squibb Co., moving on to management positions at Alexion Pharmaceuticals, Inc. and T Cell Sciences, Inc. (now Celldex Therapeutics, Inc.). . He has a B.S. in Biology from St. Lawrence University and Ph.D. in Physiology from the University of Virginia.
I think he is REAL granted MLV is doing the ATM, but anyone with half a brain would not put out a research report just to get some business. It would be a huge issue.
Also a buddy of mine who works for a Biotech IB has told me George is very reputable.
The ATM is adding CASH that we need to get rid of some concerns.
Instead of second guessing the day to day operations of a biotech, sell it, or set a date when you will start your exit plan. If you hate it, sell your shares......
I also have a July 1st target to see some real movement. Maybe something for AACR, but we know ASCO is do or die. I feel its do, I am long, both the equity and July options.
Its so funny how quick everyone jumps from bull to bear on this board. From my past dealings i think everything is bullish from today being down, to the nonsense this board has become.
Market Data 
Markets 
AI
